In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: Results from the 2017 surveillance of multicenter antimicrobial resistance in Taiwan (SMART)

Jean S.-S.Lu M.-C.Shi Z.-Y.Tseng S.-H.Wu T.-S.Lu P.-L.PEI-LAN SHAOKo W.-C.Wang F.-D.PO-REN HSUEH2020-03-272020-03-2720181178-6973https://scholars.lib.ntu.edu.tw/handle/123456789/479729In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: Results from the 2017 surveillance of multicenter antimicrobial resistance in Taiwan (SMART)journal article10.2147/IDR.S1756792-s2.0-85057576101